CD274 and familial pancreatic carcinoma: In summary, our results indicate that PD1-CD28 fusion protein transduced CD4+ T cells have the potential to overcome the PD-1-PD-L1 immunosuppressive axis in pancreatic cancer and non-Hodgkin-lymphoma.